Literature DB >> 34051201

Lung cancer mortality attributable to residential radon exposure in Spain and its regions.

Alberto Ruano-Ravina1, Leonor Varela Lema2, Marta García Talavera3, Montserrat García Gómez4, Santiago González Muñoz4, María Isolina Santiago-Pérez5, Julia Rey-Brandariz6, Juan Barros-Dios2, Mónica Pérez-Ríos2.   

Abstract

Lung cancer has the highest cancer mortality rate in developed countries. The principal risk factor for lung cancer is tobacco use, with residential radon being the leading risk factor among never smokers and the second among ever smokers. We sought to estimate mortality attributable to residential radon exposure in Spain and its Autonomous Regions, with correction for dwelling height and differentiation by tobacco use. We applied a prevalence-based method for estimating attributable mortality. For estimations, we considered exposure to radon in the different Autonomous Regions corrected for dwelling height, using the National Statistics Institute Housing Census and prevalence of tobacco use (never smokers, smokers and ex-smokers). The results showed that 3.8% (838 deaths) of lung cancer mortality was attributable to radon exposure of over 100 Bq/m3, a figure that rises to 6.9% (1,533 deaths) when correction for dwelling height is not performed. By Autonomous Region, the highest population attributable fractions, corrected for dwelling height, were obtained for Galicia, Extremadura, and the Canary Islands, where 7.0, 6.9, and 5.5% of lung cancer mortality was respectively attributable to radon exposure. The greatest part of the attributable mortality occurred in men and among smokers and ex-smokers. Residential radon exposure is a major contributor to lung cancer mortality, though this contribution is highly variable among the different territories, indicating the need for targeted prevention policies. Correction of estimates for dwelling height is fundamental for providing reliable estimates of radon-attributable mortality.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Attributable mortality; Indoor radon; Lung neoplasms; Spain

Year:  2021        PMID: 34051201     DOI: 10.1016/j.envres.2021.111372

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  6 in total

1.  National Radon Action Plans in Europe and Need of Effectiveness Indicators: An Overview of HERCA Activities.

Authors:  Francesco Bochicchio; David Fenton; Heloísa Fonseca; Marta García-Talavera; Pierrick Jaunet; Stephanie Long; Bård Olsen; Jelena Mrdakovic Popic; Wolfgang Ringer
Journal:  Int J Environ Res Public Health       Date:  2022-03-30       Impact factor: 3.390

Review 2.  Impacts of Indoor Radon on Health: A Comprehensive Review on Causes, Assessment and Remediation Strategies.

Authors:  Leonel J R Nunes; António Curado; Luís C C da Graça; Salete Soares; Sérgio Ivan Lopes
Journal:  Int J Environ Res Public Health       Date:  2022-03-25       Impact factor: 3.390

3.  Determination of the indoor radon concentration in schools of Tenerife (Canary Islands): a comparative study.

Authors:  María López-Pérez; Francisco Hernández; Juan Pedro Díaz; Pedro A Salazar-Carballo
Journal:  Air Qual Atmos Health       Date:  2022-03-29       Impact factor: 5.804

Review 4.  The Role of Mitochondrial miRNAs in the Development of Radon-Induced Lung Cancer.

Authors:  Assiya Kussainova; Olga Bulgakova; Akmaral Aripova; Zumama Khalid; Rakhmetkazhi Bersimbaev; Alberto Izzotti
Journal:  Biomedicines       Date:  2022-02-11

5.  Age does matter in adolescents and young adults vs. older adults with lung adenocarcinoma: A retrospective analysis comparing clinical characteristics and outcomes in response to systematic treatments.

Authors:  Lin Zhou; Huiwu Li; Shuhui Yang
Journal:  Oncol Lett       Date:  2022-08-31       Impact factor: 3.111

6.  [Lung cancer mortality trends in Colombia, 1985-2018Tendências na mortalidade por câncer de pulmão na Colômbia de 1985 a 2018].

Authors:  Alexandra Giraldo-Osorio; Alberto Ruano-Ravina; Julia Rey-Brandariz; Nelson Arias-Ortiz; Cristina Candal-Pedreira; Mónica Pérez-Ríos
Journal:  Rev Panam Salud Publica       Date:  2022-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.